Geropharm

Quick facts

Marketed products

• Apidra® SoloStar®
• Prezista® · Infectious Disease
  Prezista (darunavir) is a protease inhibitor that blocks HIV protease, preventing the cleavage of viral polyproteins and inhibiting viral replication.

Phase 3 pipeline

• GP40071 · Cardiovascular
  GP40071 is a small molecule drug that targets the renin-angiotensin system.
• GP40081 · Neurology
  GP40081 is a small molecule drug that targets the sigma-1 receptor.
• GP40321 · Psychiatry
  GP40321 is a small molecule that targets the serotonin receptor.
• GP404141 · Immunology
  GP404141 is a small molecule drug that targets the S1P receptor.
• Insulin Humulin® NPH · Diabetes
  Insulin Humulin NPH is a human insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
• Insulin Lispro Biphasic 25 · Diabetes
  Insulin Lispro Biphasic 25 is a premixed insulin formulation that rapidly lowers blood glucose by facilitating cellular glucose uptake and storage.
• Insulin Rinsulin® NPH · Diabetes
  Insulin NPH is a long-acting basal insulin that binds to insulin receptors on cells to promote glucose uptake and utilization, lowering blood glucose levels.
• NovoRapid® Penfill® · Diabetes
  NovoRapid is a rapid-acting insulin analog that binds to insulin receptors to facilitate glucose uptake and utilization in cells.
• RinGlar® · Diabetes
  RinGlar is a glucagon-like peptide-1 (GLP-1) receptor agonist.

Phase 1 pipeline

• Glucophage® Long
• GP-40081
• GP30101
• GP40141
• GP40221
• Humalog® Mix 25
• Humulin® M3
• Humulin NPH
• Humulin® Regular
• NovoMix® 30 Penfill®
• Rinsulin NPH
• Rinsulin® R

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Geropharm portfolio CI brief
• Geropharm pipeline updates RSS